1. Home
  2. BCAX vs SENS Comparison

BCAX vs SENS Comparison

Compare BCAX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • SENS
  • Stock Information
  • Founded
  • BCAX 2018
  • SENS 1996
  • Country
  • BCAX United States
  • SENS United States
  • Employees
  • BCAX N/A
  • SENS N/A
  • Industry
  • BCAX
  • SENS Industrial Machinery/Components
  • Sector
  • BCAX
  • SENS Industrials
  • Exchange
  • BCAX NYSE
  • SENS Nasdaq
  • Market Cap
  • BCAX 733.5M
  • SENS 619.1M
  • IPO Year
  • BCAX 2024
  • SENS N/A
  • Fundamental
  • Price
  • BCAX $13.00
  • SENS $0.96
  • Analyst Decision
  • BCAX Strong Buy
  • SENS Strong Buy
  • Analyst Count
  • BCAX 6
  • SENS 1
  • Target Price
  • BCAX $39.50
  • SENS $2.00
  • AVG Volume (30 Days)
  • BCAX 327.7K
  • SENS 10.6M
  • Earning Date
  • BCAX 03-04-2025
  • SENS 03-03-2025
  • Dividend Yield
  • BCAX N/A
  • SENS N/A
  • EPS Growth
  • BCAX N/A
  • SENS N/A
  • EPS
  • BCAX N/A
  • SENS N/A
  • Revenue
  • BCAX N/A
  • SENS $22,205,000.00
  • Revenue This Year
  • BCAX N/A
  • SENS $0.43
  • Revenue Next Year
  • BCAX N/A
  • SENS $60.55
  • P/E Ratio
  • BCAX N/A
  • SENS N/A
  • Revenue Growth
  • BCAX N/A
  • SENS 11.41
  • 52 Week Low
  • BCAX $11.10
  • SENS $0.25
  • 52 Week High
  • BCAX $28.09
  • SENS $1.40
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • SENS 49.34
  • Support Level
  • BCAX N/A
  • SENS $1.00
  • Resistance Level
  • BCAX N/A
  • SENS $1.40
  • Average True Range (ATR)
  • BCAX 0.00
  • SENS 0.12
  • MACD
  • BCAX 0.00
  • SENS -0.02
  • Stochastic Oscillator
  • BCAX 0.00
  • SENS 28.67

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: